| Bioactivity | DMTr-LNA-C(Bz)-3-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | DMTr-LNA-C(Bz)-3-CED-phosphoramidite |
| CAS | 206055-78-9 |
| Formula | C47H52N5O9P |
| Molar Mass | 861.92 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
DMTr-LNA-C(Bz)-3-CED-phosphoramidite
CAS: 206055-78-9 F: C47H52N5O9P W: 861.92
DMTr-LNA-C(Bz)-3-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activ
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.